Anti-angiogenic and anti-HER therapy

Giampietro Gasparini, Roberta Sarmiento, Raffaele Longo

Research output: Contribution to journalArticlepeer-review


The recent completion of the human genome sequence provided the basis and the tools to better understand the cellular biological complexity in both healthy and disease conditions, such as human cancer. In recent years, the improvement in biological and molecular knowledge enabled us to identify new targets and innovative drugs, allowing the beginning of new therapeutic strategies based on the so called "target oriented therapies".

Original languageEnglish
Pages (from-to)263-265
Number of pages3
JournalBiomedicine and Pharmacotherapy
Issue number6
Publication statusPublished - Jul 2006


  • Angiogenesis
  • Molecular-target therapy
  • Vascular endothelial growth factor (VEGF)

ASJC Scopus subject areas

  • Pharmacology


Dive into the research topics of 'Anti-angiogenic and anti-HER therapy'. Together they form a unique fingerprint.

Cite this